| Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade Z Wang, EG Aguilar, JI Luna, C Dunai, LT Khuat, CT Le, A Mirsoian, ... Nature medicine 25 (1), 141-151, 2019 | 627 | 2019 |
| NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype E Ames, RJ Canter, SK Grossenbacher, S Mac, M Chen, RC Smith, ... The Journal of Immunology 195 (8), 4010-4019, 2015 | 209 | 2015 |
| Outcomes of patients with esophageal cancer staged with [18F] fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility … AM Monjazeb, G Riedlinger, M Aklilu, KR Geisinger, G Mishra, S Isom, ... Journal of Clinical Oncology 28 (31), 4714, 2010 | 156 | 2010 |
| Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy MN Bouchlaka, GD Sckisel, M Chen, A Mirsoian, AE Zamora, E Maverakis, ... Journal of Experimental Medicine 210 (11), 2223-2237, 2013 | 155 | 2013 |
| 15-Deoxy-Δ12, 14-prostaglandin J2-induced apoptosis does not require PPARγ in breast cancer cells CE Clay, A Monjazeb, J Thorburn, FH Chilton, KP High Journal of lipid research 43 (11), 1818-1828, 2002 | 148 | 2002 |
| Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? S Demaria, C Guha, J Schoenfeld, Z Morris, A Monjazeb, A Sikora, ... Journal for immunotherapy of cancer 9 (4), 2021 | 144 | 2021 |
| Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice A Mirsoian, MN Bouchlaka, GD Sckisel, M Chen, CCS Pai, E Maverakis, ... Journal of Experimental Medicine 211 (12), 2373-2383, 2014 | 136 | 2014 |
| Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD (L)-1 … JD Schoenfeld, A Giobbie-Hurder, S Ranasinghe, KZ Kao, A Lako, J Tsuji, ... The Lancet Oncology 23 (2), 279-291, 2022 | 132 | 2022 |
| Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity GD Sckisel, MN Bouchlaka, AM Monjazeb, M Crittenden, BD Curti, ... Immunity 43 (2), 240-250, 2015 | 127 | 2015 |
| Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial RJ Canter, SK Grossenbacher, JA Foltz, IR Sturgill, JS Park, JI Luna, ... Journal for immunotherapy of cancer 5, 1-16, 2017 | 117 | 2017 |
| Canine cancer immunotherapy studies: linking mouse and human JS Park, SS Withers, JF Modiano, MS Kent, M Chen, JI Luna, WTN Culp, ... Journal for immunotherapy of cancer 4, 1-11, 2016 | 117 | 2016 |
| Minimal PD-1 expression in mouse and human NK cells under diverse conditions SJ Judge, C Dunai, EG Aguilar, SC Vick, IR Sturgill, LT Khuat, KM Stoffel, ... The Journal of Clinical Investigation 130 (6), 3051-3068, 2020 | 113 | 2020 |
| Blocking indolamine-2, 3-dioxygenase rebound immune suppression boosts antitumor effects of radio-immunotherapy in murine models and spontaneous canine malignancies AM Monjazeb, MS Kent, SK Grossenbacher, C Mall, AE Zamora, ... Clinical Cancer Research 22 (17), 4328-4340, 2016 | 105 | 2016 |
| Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols MT Silvestrini, ES Ingham, LM Mahakian, A Kheirolomoom, Y Liu, BZ Fite, ... JCI insight 2 (6), 2017 | 102 | 2017 |
| The challenge for development of valuable immuno-oncology biomarkers JM Mehnert, AM Monjazeb, JMT Beerthuijzen, D Collyar, L Rubinstein, ... Clinical Cancer Research 23 (17), 4970-4979, 2017 | 99 | 2017 |
| Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion N Jiang, B Xie, W Xiao, M Fan, S Xu, Y Duan, Y Hamsafar, AC Evans, ... Nature communications 13 (1), 1511, 2022 | 98 | 2022 |
| Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells D Candas-Green, B Xie, J Huang, M Fan, A Wang, C Menaa, Y Zhang, ... Nature communications 11 (1), 4591, 2020 | 96 | 2020 |
| Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells E Ames, RJ Canter, SK Grossenbacher, S Mac, RC Smith, AM Monjazeb, ... OncoImmunology 4 (9), e1036212, 2015 | 82 | 2015 |
| Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer ME Daly, AM Monjazeb, K Kelly Journal of Thoracic Oncology 10 (12), 1685-1693, 2015 | 81 | 2015 |
| Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas SJ Judge, MA Darrow, SW Thorpe, AA Gingrich, EF O'Donnell, AR Bellini, ... Journal for immunotherapy of cancer 8 (2), 2020 | 77 | 2020 |
Robert CanterUC DavisVerified email at ucdavis.edu
